A further new species for the genus Ananteris Thorell, 1891 (Scorpiones: Ananteridae) from a poorly prospected region of Brazilian Amazonia

Posted by
  A further new species for the genus Ananteris Thorell, 1891 (Scorpiones: Ananteridae) from a poorly prospected region of Brazilian Amazonia Abstract  A new species of the genus Ananteris Thorell, 1891 is described from the region which today defines the ‘Reserva Biológica do Río Trombetas’ in the state of Pará, Brazil. The collection of the unique specimen, presently study, took place previously to the definition of this reserve, in a joint field trip with a team of the Instituto Brasileiro de Desenvolvimento Florestal (IBDF). Ananteris antoni sp. n. is described based on one female specimen collected in a zone of dense humid forest, under death log. With this new description, the number of Ananteris species known for the scorpion fauna of Brazil is now raised to 33. Lourenço W. R., 2026. – A further new species for the genus Ananteris Thorell, 1891 (Scorpiones: Ananteridae) from a poorly prospected region of Brazilian Amazonia. Faunitaxys, 14(63): 1 – 5.  https://doi.o...

The bioprospecting potential of insect venoms as antibiotics: a mini review

Posted by

 


The bioprospecting potential of insect venoms as antibiotics: a mini review

The global rise of antimicrobial resistance has intensified the search for new antibiotic candidates from unconventional biological sources. Insect venoms, although underexplored compared to other venomous taxa, harbor a chemically diverse array of antimicrobial peptides (AMPs) with significant therapeutic promises. This mini review synthesizes evidence from 15 original studies published over the past 15 years that examined the antimicrobial potential of insect venom components. Most investigations have focused on Hymenoptera—wasps, bees, and ants—where peptides such as mastoparans, polydim-I, macropin, melectin, and panurgines that exhibit broad-spectrum activity against multidrug-resistant bacteria while maintaining low toxicity toward mammalian cells. Collectively, these findings highlight insect venoms as a promising resource for antibiotic discovery. Nevertheless, critical challenges remain regarding peptide stability, delivery, pharmacokinetics, and clinical validation. Addressing these gaps through integrative approaches combining molecular, computational, and translational research will be key to advancing insect venom peptides as next-generation anti-infective agents.

Riva, H. G., & R., A. (2025). The bioprospecting potential of insect venoms as antibiotics: A mini review. Frontiers in Microbiology, 16, 1729786. https://doi.org/10.3389/fmicb.2025.1729786